News
T-cell acute lymphoblastic leukaemia (T-ALL) is a paediatric leukaemia associated with distinct clinical and biological characteristics. Historically linked with a poor prognosis, T-ALL represents ...
Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.
A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...
The work is published in the journal Biomarker Research. B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results